Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
Date:11/3/2009

P basis Onyx recorded net income of $21.7 million, or $0.37 per diluted share, compared with a net income of $32.1 million, or $0.57 per diluted share, for the same period in 2008.

Management Conference Call Today

Onyx will host a teleconference and webcast to provide a general business overview and discuss financial results. The event will begin at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on November 3, 2009. The live webcast will be available at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

or by dialing 847-619-6547 and using the passcode 25674242. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 25674242 approximately one hour after the teleconference concludes. The replay will be available through December 3, 2009.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, is developing and marketing Nexavar(®) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit http://www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include, without limitation, statements regarding sales trends and commercial activities, the timing, progress and results of clinical development
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
2. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
3. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
4. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
5. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
6. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
7. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
8. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
9. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
10. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
11. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 The typical Thanksgiving dinner table ... plenty of gravy and a myriad of mouthwatering desserts. ... time of year to begin losing weight? Listen closely. ... the secret to losing unhealthy, embarrassing and uncomfortable fat ... , The insight to Diet Doc’s calorie loading ...
(Date:11/21/2014)... Ft. Lauderdale, Florida (PRWEB) November 21, 2014 ... system for chronic headaches and other jaw-related ... of patients seeking relief from chronic head pain, neck ... vertigo. , “This year we have seen a ... have treated. Our network of over 300 doctors and ...
(Date:11/21/2014)... Even with years of experience under his ... room for growth, participating in two recent events for his ... Convention, a networking event with the leaders of State Farm ... the latest and greatest in insurance news and products for ... his team (Stacy, Anthony, Reina and Jacob) as exhibitors at ...
(Date:11/21/2014)... First Choice Emergency Room ... new facility is located at 225 E. Parkwood Drive, ... are pleased to join the Friendswood community and look ... here,” said Dr. Siddiqi, Facility Medical Director of First ... the opening, First Choice Emergency Room made a donation ...
(Date:11/21/2014)... Dennis Thompson HealthDay Reporter ... of gel into the wall of a still-beating heart has ... heart failure, according to a new study. Heart patients ... and were able to walk hundreds of feet farther during ... He is chief of the cardiovascular division at Washington University ...
Breaking Medicine News(10 mins):Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4Health News:National Rise In Patients Seeking Headache Relief 2Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3
... HealthDay Reporter , MONDAY, Feb. 6 (HealthDay News) -- ... in cars, more than 20 percent of nonsmoking teens still ... particularly intense in a closed space, such as inside a ... "There have been marked decreases in exposure to smoking ...
... News) -- Treatment with three relatively new cancer drugs ... death, a new analysis suggests. While the risk ... doctors and patients, according to Dana-Farber Cancer Institute scientists ... 10 clinical trials that included nearly 4,700 patients treated ...
... -- A new scoring system can help quickly identify stroke ... (Activase), Finnish researchers say. Their study, published in the ... 1,319 ischemic stroke patients, average age 69, who were treated ... caused by blocked blood flow to the brain. The ...
... A recent discovery by Van Andel Research Institute ... proposed drug therapies for glioblastoma the most common ... The study, published in January in the Proceedings ... models characterized by cell signaling activation and gene amplification ...
... worst recessions in nearly a century, hundreds of thousands of ... jobs and the health plans that came with those jobs, ... Health Policy Research. Among the most alarming ... in California,s already high rate of residents with medical debt. ...
... running for 30 years, has finally provided convincing evidence ... the symptoms of painful menstrual periods reports scientists from ... is published in Europes leading reproductive medicine journal ... evidence have suggested that the combined oral contraceptive pill ...
Cached Medicine News:Health News:Fewer Teens Exposed to Tobacco Smoke in Cars: Report 2Health News:Fewer Teens Exposed to Tobacco Smoke in Cars: Report 3Health News:Certain Cancer Drugs May Have Fatal Side Effects: Analysis 2Health News:New Scoring Method May Help Predict Stroke Outcome 2Health News:Discovery predicts patient sensitivity to important drug target in deadly brain cancer 2Health News:Medical debt keeps rising, new report shows 2Health News:Medical debt keeps rising, new report shows 3Health News:Combined oral contraceptive pill helps painful periods 2Health News:Combined oral contraceptive pill helps painful periods 3Health News:Combined oral contraceptive pill helps painful periods 4
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)... 21, 2014  World Hemp Oil, an importer of ... they are now offering legal, organic oil with high ... strains grown in medical marijuana states. People suffering from ... as Parkinson,s, MS, and spinal cord injury, no longer ... because imported CBD Oil Is legal in all states. ...
(Date:11/21/2014)... 21. November 2014 ... bekannt gegeben, dass die Europäische Arzneimittel-Agentur ... Kennzeichnung als Orphan-Medizinprodukt an Palovarotene vergeben ... zur Behandlung von Fibrodysplasia ossificans progressiva ... beeinträchtigende genetische Krankheit, die von schmerzhaften, ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), ... present a company overview at Bank of America  Merrill Lynch,s ... at 1:40 p.m. PT at the Encore at the Wynn ... the presentation will be available on the "Investors & Media" ...
... MIAMI, May 3, 2011 GenerationOne and Cincinnati Children,s ... for testing mobile technology in aiding the management of ... an appealing technology for tailoring interventions and bridging knowledge ... in this area. This study will serve as a ...
Cached Medicine Technology:GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics 2GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics 3
... with each kit maximizes suction efficiency and ... Pour Pak® II suction catheter products are ... II suction catheter kits help minimize the ... and clinician from exposure to contaminated material ...
... The Maxi-Flo® suction catheter included with each ... trauma., ,All Portex® No Pour Pak® ... ,No Pour Pak® II suction ... nosocomial infections, protecting the patient and clinician ...
... Completely disposable. Components packaged in ... of use. Choice of multi-compartment ... of use. Economical.Prevents waste by ... be packaged sterile or non-sterile. ...
... Patient Trauma and Increase Staff Protection With ... Fr, 12 Fr, 14 Fr, 16 Fr ... Catheters with Contro-Vac Valves and DeLee or ... for inflammation,during suctioning. Each catheter utilizes a ...
Medicine Products: